Health Care · Services-Hospitals

EHC Encompass Health Corp SEC Filings & Insider Trading Activity 2026

company
CIK 785161121 filings

EHC at a glance

Encompass Health Corp (EHC, SEC CIK 785161) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 6, 2026 and Form 4 insider filings as recently as October 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Encompass Health Corp (EHC) reported revenue of $5.9 billion (up 10.5% from FY2024) and net income of $566.2 million. Diluted EPS was $5.54.
  • As of September 30, 2026, 40 institutional investment managers tracked by SignalX reported holding Encompass Health Corp (EHC) shares worth $5.7 billion in 13F-HR filings.
  • In the last 90 days, EHC insiders reported 0 open-market purchases ($0) and 2 open-market sales ($1.2M) on Form 4, a net sale of $1.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$5.9B
+10.5% vs prior year
Insiders · 90 days
0 buys · 2 sells
Net −$1.2M
13F holders
40 funds
$5.7B · +1 vs prior quarter
Latest 8-K
Nov 6, 2026
Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes from 2025 Form 10-K risk factors
  • Updated risk information incorporated from MD&A’s “Executive Overview, Key Challenges” section

Management Discussion & Analysis

  • Revenue $1,609.5M, up 8.9% YoY, driven by 5.7% discharge growth and 4.0% higher revenue per discharge
  • Net income attributable to Encompass Health $149.9M, up 18.5% YoY; operating expenses 82.1% vs 83.5% of revenue
  • Inpatient revenue $1,569.1M, up 9.9% YoY; other revenue $40.4M, down 19.5%
  • Cash $76.2M; operating cash flow $957.7M through nine months vs $829.6M; capital expenditures approximately $617M
  • Outlook: 2027 IRF rule expected to increase Medicare payment rates approximately 2.3%; RCD expansion affects 108 IRFs and approximately 63% of Medicare claims

AI summary of the EHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 6, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Sea Pines, a 90-bed joint-venture hospital, closed indefinitely after flooding caused substantial damage
  • Reopening requires refurbishment or replacement, creating uncertain timing and potential capital needs

Item 7.01: Regulation FD Disclosure

  • Press release announces storm-related damage at one Florida hospital, creating potential disruption, repair costs, and temporary operating pressure
  • Investor impact depends on facility downtime, insurance recovery, and whether damage affects systemwide Adjusted EBITDA or debt covenants
Filed Oct 28, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q3 revenue $1,609.5M, up 8.9%, with discharges up 5.7% and revenue per discharge up 4.0%
  • Adjusted EBITDA $346.6M, up 15.5%, outpacing revenue growth and supporting operating leverage

Item EX-99.2: Item EX-99.2

  • Q3 revenue $1,609.5M, up 8.9%, with discharges up 5.7% and revenue per discharge up 4.0%
  • Adjusted EBITDA $346.6M, up 15.5%, expanding operating leverage despite higher bad-debt reserves

Item 7.01: Regulation FD Disclosure

  • Supplemental earnings information scheduled for October 29, 2026, providing investors additional operating and financial detail
  • Key metrics include adjusted EPS, Adjusted EBITDA, leverage ratio, and adjusted free cash flow

Item 2.02: Results of Operations and Financial Condition

  • Encompass Health reported financial results for the three and nine months ended September 30, 2026
  • Press release containing detailed results attached as Exhibit 99.1
Filed Aug 13, 2026Full analysis →

Item 8.01: Other Events

  • $100 million 5.875% senior notes issued, due 2034, expanding total notes under the indenture to $600 million
  • 98.75% issue price, approximately $96.9 million net proceeds after discounts and expenses

AI summaries of EHC 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for EHC

Don't miss the next EHC filing

  • Alerts as it files. A push when EHC files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut EHC, by share count.
  • Ask anything. An AI agent that reads every EHC filing and answers with sources.

EHC alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Christie Edward M IIIAOct 19, 2026$126.63
Reidy Christopher RAOct 19, 2026$126.89
SCHLICHTING NANCY MAOct 15, 2026-
Williams TerranceAOct 15, 2026-
Christie Edward M IIIAOct 15, 2026-
O'Connor Kevin J.AOct 15, 2026-
Reidy Christopher RAOct 15, 2026-
Hayes Cain AAOct 15, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$4.8B$5.4B$5.9B
Net Income$352.0M$455.7M$566.2M
Net Margin7.3%8.5%9.5%
Balance Sheet
Total Assets$6.1B$6.5B$7.1B
Equity$1.6B$2.1B$2.4B
ROE21.4%22.0%23.2%
Per Share
EPS$3.47$4.46$5.54
Cash Flow
Operating CF$850.8M$1.0B$1.2B

Source: XBRL data in Encompass Health Corp (EHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate EHC share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
EHC shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202640$5.71B
Q2 202639$4.81B
Q1 202639$4.62B
Q4 202536$4.97B
Q3 202537$6.18B
Q2 202537$5.55B
Q1 202536$3.54B
Q4 202429$2.76B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 293 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

EHC filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 6, 2026Analysis-
10-QNov 3, 2026Analysis
8-KOct 28, 2026Analysis-
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Oct 19, 2026--
4Sep 1, 2026--
4Sep 1, 2026--
8-KAug 13, 2026Analysis-
4Aug 11, 2026--
4Aug 11, 2026--
4Aug 11, 2026--
10-QAug 7, 2026-
8-KAug 5, 2026Analysis-
4Jul 16, 2026--
4Jul 16, 2026--
4Jul 16, 2026--
4Jul 16, 2026--
4Jul 16, 2026--

Related Health Care companies

All Health Care →

EHC SEC filings: frequently asked questions

Are EHC insiders buying or selling?

In the last 90 days, Encompass Health Corp (EHC) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $1.2 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold EHC stock?

As of September 30, 2026, the largest Encompass Health Corp (EHC) holders among the 13F filers tracked by SignalX were BlackRock ($1.3 billion), T. Rowe Price Group ($668.0 million), Vanguard Portfolio Management LLC ($595.0 million), Vanguard Capital Management LLC ($536.8 million), State Street Corp ($387.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was EHC's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Encompass Health Corp (EHC) reported revenue of $5.9 billion (up 10.5% from FY2024) and net income of $566.2 million. Diluted EPS was $5.54. The figures come from the XBRL data in the 10-K.

What did EHC report in its latest 8-K?

Encompass Health Corp (EHC) filed an 8-K on November 6, 2026 reporting Item 7.01 (Regulation FD Disclosure). Sea Pines, a 90-bed joint-venture hospital, closed indefinitely after flooding caused substantial damage.

What are the latest EHC SEC filings?

Encompass Health Corp (EHC) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 6, 2026 and a Form 4 insider filing on October 19, 2026.

What is EHC's SEC CIK number?

Encompass Health Corp (EHC)'s SEC Central Index Key (CIK) is 785161. EDGAR lists every EHC filing under that number.

Ask anything about EHC

The research agent reads EHC's filings, financials, insider trades and 13F holders, then answers with sources.